PolyPid Ltd. (PYPD)
5.02
+0.19
(+3.93%)
USD |
NASDAQ |
May 22, 16:00
5.04
+0.02
(+0.40%)
After-Hours: 20:00
PolyPid Enterprise Value : 87.49M for May 22, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Teva Pharmaceutical Industries Ltd. | 52.84B |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 168.62M |
| Purple Biotech Ltd. | -3.623M |
| Sol-Gel Technologies Ltd. | 190.75M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.728M |
| Total Expenses (Quarterly) | 7.728M |
| EPS Diluted (Quarterly) | -0.3525 |
| Earnings Yield | -38.10% |
| Normalized Earnings Yield | -38.10 |